TGFB1 and Miyoshi myopathy: These results are consistent with the notion that TGF-β inhibition potentiates BMP-2 action and releases OB precursor cells from the blockade of BMP-2 signaling by TGF-β without affecting canonical Wnt signaling down-regulated by MM cells.